Vilazodone for Corticosteroid-Induced Memory Impairment
Phase of Trial: Phase II
Latest Information Update: 12 Apr 2019
Price : $35 *
At a glance
- Drugs Vilazodone (Primary)
- Indications Generalised anxiety disorder; Major depressive disorder; Social phobia
- Focus Therapeutic Use
- 25 Mar 2015 Status changed from active, no longer recruiting to completed,as reported by ClinicalTrials.gov.
- 15 Apr 2014 Trial status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 22 Apr 2013 New trial record